tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Minerva Neurosciences Inc

NERV
Add to Watchlist
3.980USD
-0.040-0.99%
Close 07-31 16:00（ET）Quotes delayed by 15 min
185.42MMarket Cap
LossP/E TTM

Minerva Neurosciences Inc

3.980
-0.040-0.99%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

NERV Financials

See Minerva Neurosciences Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Minerva Neurosciences Inc Earnings Date

Latest Release
May 7, 2026
EPS / Forecast
-2.86/-0.13
Revenue / Forecast
--/0.00
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-34.67
-18337.20%
Analyst Rating
HOLD
2026/08/01
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-476.11%-2.86
-4408.53%-25.45
-112.19%-0.36
60.42%-0.43
56.20%-0.50
52.58%-0.56
387.88%2.97
3.18%-1.09
13.27%-1.13
5.50%-1.19
---1.03
---1.12
---1.31
---1.26
---4.75
----
----
----
----
----
Revenue
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
-100.00%0.00
Net Profit
-3241.47%-125.40M
-6540.09%-283.67M
-112.19%-2.74M
60.42%-3.26M
56.20%-3.75M
52.65%-4.27M
387.88%22.51M
-32.97%-8.23M
-22.93%-8.57M
-34.14%-9.02M
-13.33%-7.82M
28.97%-6.19M
28.61%-6.97M
68.43%-6.73M
25.04%-6.90M
17.67%-8.72M
-10.90%-9.76M
-190.88%-21.31M
-13.47%-9.21M
-135.86%-10.59M
Debt to assets ratio
--63.81%
--61.24%
--213.58%
--197.24%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Income Statement
Revenue
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
-100.00%0.00
Operating profit
-327.16%-16.67M
-10.16%-4.98M
34.86%-2.84M
46.25%-3.37M
41.59%-3.90M
36.95%-4.52M
28.17%-4.37M
-38.88%-6.28M
-24.93%-6.68M
-41.47%-7.17M
-16.75%-6.08M
35.11%-4.52M
33.05%-5.35M
76.28%-5.07M
30.73%-5.21M
22.29%-6.97M
-6.42%-7.99M
-192.86%-21.38M
7.08%-7.52M
-130.38%-8.96M
Net Profit
-3241.47%-125.40M
-6540.09%-283.67M
-112.19%-2.74M
60.42%-3.26M
56.20%-3.75M
52.65%-4.27M
387.88%22.51M
-32.97%-8.23M
-22.93%-8.57M
-34.14%-9.02M
-13.33%-7.82M
28.97%-6.19M
28.61%-6.97M
68.43%-6.73M
25.04%-6.90M
17.67%-8.72M
-10.90%-9.76M
-190.88%-21.31M
-13.47%-9.21M
-135.86%-10.59M
Balance Sheet
Current assets
341.32%79.11M
273.16%83.10M
-53.39%13.02M
-50.50%15.55M
-49.68%17.92M
-46.98%22.27M
-42.07%27.94M
-39.86%31.41M
-2.87%35.62M
4.59%42.00M
7.55%48.23M
4.37%52.23M
-34.15%36.67M
-35.44%40.16M
-33.51%44.84M
-33.48%50.04M
-31.82%55.70M
126.68%62.20M
92.74%67.44M
109.59%75.23M
Total current liabilities
130.19%4.48M
-19.26%2.29M
-40.39%2.67M
-39.84%2.53M
-31.21%1.95M
-15.08%2.84M
33.84%4.48M
120.33%4.20M
13.16%2.83M
142.49%3.34M
52.47%3.35M
-44.04%1.91M
-22.97%2.50M
-51.13%1.38M
-28.74%2.20M
-23.30%3.41M
-3.30%3.25M
-10.80%2.82M
-42.85%3.08M
-39.96%4.44M
Total assets
186.68%94.03M
163.76%97.97M
-34.38%28.09M
-34.29%30.42M
-35.07%32.80M
-34.72%37.14M
-32.18%42.81M
-31.05%46.29M
-2.10%50.51M
3.29%56.90M
5.64%63.13M
3.35%67.14M
-26.94%51.59M
-28.57%55.09M
-38.75%59.76M
-38.32%64.96M
-36.85%70.62M
33.83%77.12M
49.58%97.56M
59.18%105.32M
Total liabilities
453.83%343.08M
272.00%233.76M
-2.81%62.67M
-31.12%62.53M
-28.88%61.95M
-26.38%62.84M
-22.47%64.48M
13.98%90.78M
11.36%87.10M
13.64%85.36M
12.39%83.18M
8.60%79.65M
9.61%78.21M
8.63%75.11M
6.51%74.00M
6.05%73.34M
7.37%71.35M
1293.06%69.15M
865.31%69.48M
649.85%69.16M
Total equity
-754.41%-249.05M
-428.49%-135.79M
-59.57%-34.58M
27.83%-32.11M
20.33%-29.15M
9.71%-25.69M
-8.10%-21.67M
-255.62%-44.49M
-37.45%-36.59M
-42.12%-28.46M
-40.72%-20.05M
-49.25%-12.51M
-3515.96%-26.62M
-351.07%-20.02M
-150.74%-14.25M
-123.18%-8.38M
-101.62%-736.13K
-84.86%7.98M
-51.61%28.08M
-36.48%36.17M
Cash Flow Statement
Net operating income
-33.28%-5.43M
13.28%-4.48M
33.00%-2.92M
48.13%-2.04M
33.18%-4.07M
13.76%-5.17M
9.44%-4.35M
-1.69%-3.94M
-5180.68%-6.09M
-45.77%-5.99M
49.59%-4.81M
25.44%-3.87M
98.01%-115.41K
14.96%-4.11M
-10.52%-9.53M
12.36%-5.19M
-11.33%-5.81M
32.49%-4.83M
12.61%-8.63M
21.93%-5.92M
Net investment
---45.29M
--0.00
--0.00
--0.00
--0.00
----
----
--0.00
--0.00
100.00%0.00
--0.00
--0.00
--0.00
---16.33K
--0.00
--0.00
--0.00
--0.00
-100.00%0.00
-100.00%0.00
Net financing
--1.08M
--74.50M
---45.17K
--0.00
--0.00
----
----
-100.00%0.00
--0.00
--0.00
---86.69K
393807940.00%19.69M
--0.00
--0.00
--0.00
---5.00
-100.00%0.00
--0.00
-100.00%0.00
-100.00%0.00

FAQs

What are the current assets of Minerva Neurosciences Inc?

According to Minerva Neurosciences Inc's FY2025 earnings report, its current assets were 83.10M, with a year-on-year change of 273.16.

What are the total assets of Minerva Neurosciences Inc?

According to Minerva Neurosciences Inc's FY2025 earnings report, its total assets of Minerva Neurosciences Inc were 97.97M, with a year-on-year change of 163.76.

What are the total liabilities of Minerva Neurosciences Inc?

According to Minerva Neurosciences Inc's FY2025 earnings report, its total liabilities of Minerva Neurosciences Inc were 233.76M, with a year-on-year change of 272.00.

What is the total equity of Minerva Neurosciences Inc?

According to Minerva Neurosciences Inc's FY2025 earnings report, its total equity of Minerva Neurosciences Inc was -135.79M, with a year-on-year change of -428.49.

What is the net operating income of Minerva Neurosciences Inc?

According to Minerva Neurosciences Inc's FY2025 earnings report, its net operating income of Minerva Neurosciences Inc was -15.10M, with a year-on-year change of 30.87.

What is the Earnings Per Share (EPS) of Minerva Neurosciences Inc?

According to Minerva Neurosciences Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -34.67, with a year-on-year change of -18337.20.

What is the net income of Minerva Neurosciences Inc?

According to Minerva Neurosciences Inc's FY2025 earnings report, its net income was -293.42M, with a year-on-year change of -20492.68.

What is the debt-to-asset ratio of Minerva Neurosciences Inc?

According to Minerva Neurosciences Inc's FY2025 earnings report, its debt-to-asset ratio was 61.24, with a year-on-year change of -62.09.

What is the Return on Assets (ROA) of Minerva Neurosciences Inc?

According to Minerva Neurosciences Inc's FY2025 earnings report, its Return on Assets (ROA) was -434.34, with a year-on-year change of -14294.08.

What is the operating profit of Minerva Neurosciences Inc?

According to Minerva Neurosciences Inc's FY2025 earnings report, its operating profit was -15.10M, with a year-on-year change of 30.87.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy